POZ

Clinical trials for POZ explained in plain language.

Never miss a new study

Get alerted when new POZ trials appear

Sign up with your email to follow new studies for POZ, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Triple-Drug attack on aggressive blood cancer

Disease control Recruiting now

This study is testing a combination of three drugs (pomalidomide, orelabrutinib, and zuberitamab) in people newly diagnosed with mantle cell lymphoma, a type of blood cancer. The main goal is to see how well this combination clears the body of tiny amounts of leftover cancer cell…

Matched conditions: POZ

Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

POZ

Get alerted when new POZ trials appear

New Triple-Drug attack on aggressive blood cancer